@prefix this: <http://www.tkuhn.ch/bel2nanopub/RAru-syfifTzq8oG3NQWn_H2JxIzOSlw0vALi8bnUTKhU> .
@prefix sub: <http://www.tkuhn.ch/bel2nanopub/RAru-syfifTzq8oG3NQWn_H2JxIzOSlw0vALi8bnUTKhU#> .
@prefix beldoc: <http://resource.belframework.org/belframework/1.0/knowledge/large_corpus.bel> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix dct: <http://purl.org/dc/terms/> .
@prefix dce: <http://purl.org/dc/elements/1.1/> .
@prefix pav: <http://purl.org/pav/> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix belv: <http://www.selventa.com/vocabulary/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix sdis: <http://resource.belframework.org/belframework/1.0/namespace/selventa-legacy-diseases/> .
@prefix schem: <http://resource.belframework.org/belframework/1.0/namespace/selventa-legacy-chemical-names/> .
@prefix species: <http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=> .
@prefix occursIn: <http://purl.obolibrary.org/obo/BFO_0000066> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix orcid: <http://orcid.org/> .
sub:Head {
  this: np:hasAssertion sub:assertion ;
    np:hasProvenance sub:provenance ;
    np:hasPublicationInfo sub:pubinfo ;
    a np:Nanopublication .
}
sub:assertion {
  sub:_1 occursIn: species:9606 ;
    rdf:object schem:D-Glucose%2C%20anhydrous ;
    rdf:predicate belv:increases ;
    rdf:subject sdis:muscle%20glucose%20import ;
    a rdf:Statement .
  sub:assertion rdfs:label "path(SDIS:\"muscle glucose import\") -> a(SCHEM:\"D-Glucose, anhydrous\")" .
}
sub:provenance {
  beldoc: dce:description "Approximately 61,000 statements." ;
    dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved." ;
    dce:title "BEL Framework Large Corpus Document" ;
    pav:authoredBy sub:_3 ;
    pav:version "1.4" .
  sub:_2 prov:value "Superoxide anions are generated by means of single-electron reduction of molecular oxygen in complexes of the mitochondrial ETC (figure 1). Particularly, their production depends on the concentration of the intermediate metabolites of these complexes, and the ETC carriers in a more reduced state are capable of donating electrons to oxygen [7,20,22]. The reduced state of the ETC carriers can be achieved by an increased production of reducing equivalents in mitochondria or by a decreased electron transfer capability on (or after) these carriers [20-22]. Increase in cellular glucose uptake will lead to an increased production of reducing equivalents if metabolism is not inhibited, and this would then be accompanied by an increased concentration of electron donors for ETC." ;
    prov:wasQuotedFrom pubmed:16448517 .
  sub:_3 rdfs:label "Selventa" .
  sub:assertion prov:hadPrimarySource pubmed:16448517 ;
    prov:wasDerivedFrom beldoc: , sub:_2 .
}
sub:pubinfo {
  this: dct:created "2014-07-03T14:30:41.329+02:00"^^xsd:dateTime ;
    pav:createdBy orcid:0000-0001-6818-334X , orcid:0000-0002-1267-0234 .
}